This Article Full Text Full Text (PDF) All Versions of this Article: 34/5/1130    most recent 01.STR.0000069163.02611.B0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kohara, K. Articles by Shimokata, H. Search for Related Content PubMed PubMed Citation Articles by Kohara, K. Articles by Shimokata, H. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Genetics Home Reference Related Collections Cerebral Lacunes

(Stroke. 2003;34:1130.)
© 2003 American Heart Association, Inc.

Original Contributions

MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population

The NILS-LSA Study

Katsuhiko Kohara, MD; Michiko Fujisawa, MD; Fujiko Ando, MD; Yasuharu Tabara, PhD; Naoakira Niino, MD; Tetsuro Miki, MD Hiroshi Shimokata, MD

From the Department of Geriatric Medicine, Ehime University School of Medicine (K.K., Y.T., T.M.), and Department of Epidemiology, National Institute for Longevity Sciences (M.F., F.A., N.N., H.S.), Ehime, Japan.

Correspondence to Katsuhiko Kohara, MD, Department of Geriatric Medicine, Ehime University, School of Medicine, Shigenobu-cho, Onsen-gun, Ehime 791-0295, Japan. E-mail koharak{at}m.ehime-u.ac.jp

Background and Purpose— Silent brain infarcts (SBI) and white matter lesions are relatively common neuroimaging findings, especially in the elderly population. The genetic background for SBI and white matter lesions in a large Japanese general population was investigated.

Methods— Subjects were recruited from participants in the National Institute for Longevity Sciences, Longitudinal Study of Aging. Genotyping of methylenetetrahydrofolate reductase (MTHFR) C677T gene mutation and brain MRI examination were performed in 1721 subjects free of any history of stroke. SBI and white matter lesions were diagnosed from MRI findings.

Results— Of 1721 MRI examinations, SBI was observed in 178 (10.3%). The prevalence of SBI and white matter lesions increased with age. The prevalence of SBI was significantly higher in subjects with the MTHFR TT genotype compared with the TC+CC genotype (14.6% versus 9.5%; 42 of 288 versus 136 of 1433; ²=6.71; P=0.010). The stage of white matter lesions was not significantly different. In subjects 60 years of age (n=849), the prevalence of SBI was significantly higher in TT than TC+CC (27.7% versus 16.6%; 36 of 130 versus 119 of 719; ²=9.16; P=0.002). The prevalence of moderately advanced white matter lesions was also significantly higher in TT than TC+CC (60.7% versus 49.0%; 79 of 130 versus 352 of 719; ²=9.16; P=0.002). After correction for other risk factors, the MTHFR TT genotype was independently associated with SBI (odds ratio [OR], 1.72; 95% CI, 1.10 to 2.68; P=0.018) and moderately advanced white matter lesions (OR, 1.58; 95% CI, 1.07 to 2.33; P=0.02).

Conclusions— These findings indicate that the MTHFR TT genotype is an independent risk factor for SBI and white matter lesions in the general Japanese population, especially in elderly subjects.

Key Words: amine oxidoreductases • brain infarction • elderly • polymorphism • white matter

This article has been cited by other articles:

				L. Paternoster, W. Chen, and C. L.M. Sudlow Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects * Supplemental References Stroke, June 1, 2009; 40(6): 2020 - 2026. [Abstract] [Full Text] [PDF]

				J. Putaala, M. Kurkinen, V. Tarvos, O. Salonen, M. Kaste, and T. Tatlisumak Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke Neurology, May 26, 2009; 72(21): 1823 - 1829. [Abstract] [Full Text] [PDF]

				S. Seshadri, P. A. Wolf, A. S. Beiser, J. Selhub, R. Au, P. F. Jacques, M. Yoshita, I. H. Rosenberg, R. B. D'Agostino, and C. DeCarli Association of Plasma Total Homocysteine Levels With Subclinical Brain Injury: Cerebral Volumes, White Matter Hyperintensity, and Silent Brain Infarcts at Volumetric Magnetic Resonance Imaging in the Framingham Offspring Study Arch Neurol, May 1, 2008; 65(5): 642 - 649. [Abstract] [Full Text] [PDF]

				M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu The Homocysteine Hypothesis of Depression Am J Psychiatry, June 1, 2007; 164(6): 861 - 867. [Abstract] [Full Text] [PDF]

				Y. Suzuki, M. Fujisawa, F. Ando, N. Niino, I. Ohsawa, H. Shimokata, and S. Ohta Alcohol dehydrogenase 2 variant is associated with cerebral infarction and lacunae Neurology, November 9, 2004; 63(9): 1711 - 1713. [Abstract] [Full Text] [PDF]

				J. F. Meschia Clinically Translated Ischemic Stroke Genomics Stroke, November 1, 2004; 35(11_suppl_1): 2735 - 2739. [Abstract] [Full Text] [PDF]

				N. K. Kim, B. O. Choi, W. S. Jung, Y. J. Choi, and K. G. Choi Hyperhomocysteinemia as an independent risk factor for silent brain infarction Neurology, December 9, 2003; 61(11): 1595 - 1599. [Abstract] [Full Text] [PDF]